P535: OUTCOMES OF INVESTIGATIONAL AGENTS VS STANDARD THERAPIES IN AML AT SALVAGE 2 AND BEYOND

• Daniel Nguyen,
• Hagop Kantarjian,
• Aram Bidikian,
• Courtney Dinardo,
• Tapan Kadia,
• Naval Daver,
• Gautam Borthakur,
• Elias Jabbour,
• Musa Yilmaz,
• Nicholas Short,
• Abhishek Maiti,
• Koji Sasaki,
• Guillermo Montalban-Bravo,
• Danielle Hammond,
• Sherry Pierce,
• Michael Andreeff,
• Guillermo Garcia-Manero,
• Farhad Ravandi,
• Ghayas Issa

Affiliations

Daniel Nguyen

1 UTHealth Houston (The University of Texas Health Science Center at Houston), Internal Medicine, Houston, United States

Hagop Kantarjian

2 The University of Texas MD Anderson Cancer Center, Houston, United States

Aram Bidikian

2 The University of Texas MD Anderson Cancer Center, Houston, United States

Courtney Dinardo

2 The University of Texas MD Anderson Cancer Center, Houston, United States

Tapan Kadia

2 The University of Texas MD Anderson Cancer Center, Houston, United States

Naval Daver

2 The University of Texas MD Anderson Cancer Center, Houston, United States

Gautam Borthakur

2 The University of Texas MD Anderson Cancer Center, Houston, United States

Elias Jabbour

2 The University of Texas MD Anderson Cancer Center, Houston, United States

Musa Yilmaz

2 The University of Texas MD Anderson Cancer Center, Houston, United States

Nicholas Short

2 The University of Texas MD Anderson Cancer Center, Houston, United States

Abhishek Maiti

2 The University of Texas MD Anderson Cancer Center, Houston, United States

Koji Sasaki

2 The University of Texas MD Anderson Cancer Center, Houston, United States

Guillermo Montalban-Bravo

2 The University of Texas MD Anderson Cancer Center, Houston, United States

Danielle Hammond

2 The University of Texas MD Anderson Cancer Center, Houston, United States

Sherry Pierce

2 The University of Texas MD Anderson Cancer Center, Houston, United States

Michael Andreeff

2 The University of Texas MD Anderson Cancer Center, Houston, United States

Guillermo Garcia-Manero

2 The University of Texas MD Anderson Cancer Center, Houston, United States

Farhad Ravandi

2 The University of Texas MD Anderson Cancer Center, Houston, United States

Ghayas Issa

2 The University of Texas MD Anderson Cancer Center, Houston, United States